A genetic test for immunosuppressant dose selection?

This publication has 12 references indexed in Scilit:

• Cytochrome P-450 hPCN3, a Novel Cytochrome P-450 IIIA Gene Product That Is Differentially Expressed in Adult Human Liver: cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporin
  Published by Elsevier ,2021
• Impact of cytochrome P450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients1 2
  Transplantation, 2003
• Genotype???phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women
  Pharmacogenetics, 2003
• Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus
  Clinical Pharmacology & Therapeutics, 2003
• Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms
  American Journal of Transplantation, 2003
• Pharmacokinetics of Midazolam and 1′-Hydroxymidazolam in Chinese with Different CYP3A5 Genotypes
  Drug Metabolism and Disposition, 2002
• Explaining Interindividual Variability of Docetaxel Pharmacokinetics and Pharmacodynamics in Asians Through Phenotyping and Genotyping Strategies
  Journal of Clinical Oncology, 2002
• Co-Regulation of CYP3A4 and CYP3A5 and Contribution to Hepatic and Intestinal Midazolam Metabolism
  Molecular Pharmacology, 2002
• The genetic determinants of the CYP3A5 polymorphism
  Pharmacogenetics, 2001
• Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
  Nature Genetics, 2001